SlideShare une entreprise Scribd logo
1  sur  28
Télécharger pour lire hors ligne
Drug therapy in Diabetes www.freelivedoctor.com
Diagnosis of Diabetes www.freelivedoctor.com Fasting Random OGTT(2h) Normal <6 <7.8 Impair 6.1 – 7 7.8- 11.1 Diabetes >7 >11.1 + symptoms >11.1
Aims  of management ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Targets for non-pregnant patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Types of Insulin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Types of Insulin www.freelivedoctor.com Insulin Lispro Aspart Neutral/ regular Isophane ultratard Glargine Onset 10-20′ 30′ 1h 4h 2-4h Peak 1h 1-3h 4-6h 6-18h peak less Duration 3-5h 4-8h 8-14h 24h 20-24h
Soluble insulin / neutral /clear ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Sites of injections - Subcutaneous ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Routes of Administration   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Untoward effect of insulin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Example injections Intermediate/long acting bedtime bedtime injections Biphasic insulin Biphasic insulin www.freelivedoctor.com Short acting Short acting Short acting breakfast lunch dinner breakfast lunch dinner
Recurrent Hypo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Sick day rules ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Oral Medications to Treat Type 2 Diabetes www.freelivedoctor.com
Major Classes of Medications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Thiazolidinediones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Biguanides ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Sulfonylureas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Meglitinides ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Alpha-glucosidase Inhibitors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Efficacy  of Monotherapy with Oral Diabetes Agents DeFronzo  Annals of Internal Medicine  1999;131:281-303  Nathan  N Engl J Med  2002; 347:1342-1349  www.freelivedoctor.com
Treatment of Type 2 Diabetes Diagnosis www.freelivedoctor.com Therapeutic Lifestyle Change Combination Therapy - Oral Drug with Insulin Combination Therapy - Oral Drugs Only Monotherapy
[object Object],[object Object],[object Object],[object Object],[object Object],Combination Therapy  for Type 2 Diabetes Fixed Combination Pills www.freelivedoctor.com
Combination Therapy  for Type 2 Diabetes Biguanides Sulfonylureas www.freelivedoctor.com Insulin Alpha-glucosidase Inhibitors Meglitinide Thiazolidinediones
Clinic Checklists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Special circumstances ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
New developments www.freelivedoctor.com
www.freelivedoctor.com

Contenu connexe

Tendances (20)

Pharmacology of diabetes mellitus
Pharmacology of diabetes mellitusPharmacology of diabetes mellitus
Pharmacology of diabetes mellitus
 
Pp oral hypoglycemic agents
Pp oral hypoglycemic agentsPp oral hypoglycemic agents
Pp oral hypoglycemic agents
 
Sulfonylureas
SulfonylureasSulfonylureas
Sulfonylureas
 
Pharmacotherapy of epilepsy
Pharmacotherapy of epilepsyPharmacotherapy of epilepsy
Pharmacotherapy of epilepsy
 
Oral hypoglycaemic agents 2020
Oral hypoglycaemic agents 2020Oral hypoglycaemic agents 2020
Oral hypoglycaemic agents 2020
 
Oral hypoglycemics
Oral hypoglycemicsOral hypoglycemics
Oral hypoglycemics
 
Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)
 
Voglibose
VogliboseVoglibose
Voglibose
 
ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS ORAL HYPOGLYCEMIC AGENTS
ORAL HYPOGLYCEMIC AGENTS
 
Antihypertensive drugs naser
Antihypertensive drugs naserAntihypertensive drugs naser
Antihypertensive drugs naser
 
Statin
StatinStatin
Statin
 
Oral antidiabetics
Oral antidiabeticsOral antidiabetics
Oral antidiabetics
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Antihyperlipidemic drugs
Antihyperlipidemic drugsAntihyperlipidemic drugs
Antihyperlipidemic drugs
 
Drugs used in treatment of constipation
Drugs used in treatment of constipationDrugs used in treatment of constipation
Drugs used in treatment of constipation
 
Antihistamines - Pharmacology
Antihistamines - PharmacologyAntihistamines - Pharmacology
Antihistamines - Pharmacology
 
Biguanide
BiguanideBiguanide
Biguanide
 
Gliptins
GliptinsGliptins
Gliptins
 
Insulin analogues ppt
Insulin analogues pptInsulin analogues ppt
Insulin analogues ppt
 
Pharmacotherapy of Diabetes mellitus
Pharmacotherapy of Diabetes mellitusPharmacotherapy of Diabetes mellitus
Pharmacotherapy of Diabetes mellitus
 

Similaire à Drug therapy in diabetes

drugtherapyindiabetes-.ppt
drugtherapyindiabetes-.pptdrugtherapyindiabetes-.ppt
drugtherapyindiabetes-.pptswatipatanwal1
 
Type 1 Diabetes Mellitus
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Type 1 Diabetes MellitusJaymax13
 
Management Of Diabetes
Management Of DiabetesManagement Of Diabetes
Management Of Diabetesdoctorshazly
 
Management of diabetes mellitus
Management of diabetes mellitusManagement of diabetes mellitus
Management of diabetes mellitusSai Pavan
 
Diabetes mellitus type ii
Diabetes mellitus type iiDiabetes mellitus type ii
Diabetes mellitus type iiIqra Butt
 
Oral hypoglycaemic agents
Oral hypoglycaemic agents   Oral hypoglycaemic agents
Oral hypoglycaemic agents Haider Haider
 
Class oral hypoglycemics
Class oral hypoglycemicsClass oral hypoglycemics
Class oral hypoglycemicsRaghu Prasada
 
Oral hypoglycemic agents
Oral hypoglycemic agentsOral hypoglycemic agents
Oral hypoglycemic agentssabahat96
 
Treatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna SaqlainTreatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna SaqlainPARUL UNIVERSITY
 
alphaglucosidase inhibitors
alphaglucosidase inhibitorsalphaglucosidase inhibitors
alphaglucosidase inhibitorsVineetSaboo2
 
Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusShailaBanu3
 

Similaire à Drug therapy in diabetes (20)

drugtherapyindiabetes-.ppt
drugtherapyindiabetes-.pptdrugtherapyindiabetes-.ppt
drugtherapyindiabetes-.ppt
 
Antidiabetic agent
Antidiabetic agent Antidiabetic agent
Antidiabetic agent
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Type 1 Diabetes Mellitus
Type 1 Diabetes MellitusType 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
 
Management Of Diabetes
Management Of DiabetesManagement Of Diabetes
Management Of Diabetes
 
Diabetes
DiabetesDiabetes
Diabetes
 
Anti diabetics
Anti diabeticsAnti diabetics
Anti diabetics
 
Management of diabetes mellitus
Management of diabetes mellitusManagement of diabetes mellitus
Management of diabetes mellitus
 
Diabetes mellitus type ii
Diabetes mellitus type iiDiabetes mellitus type ii
Diabetes mellitus type ii
 
Diabetes and insulin
Diabetes and insulinDiabetes and insulin
Diabetes and insulin
 
Oral hypoglycaemic agents
Oral hypoglycaemic agents   Oral hypoglycaemic agents
Oral hypoglycaemic agents
 
Class oral hypoglycemics
Class oral hypoglycemicsClass oral hypoglycemics
Class oral hypoglycemics
 
Nursing Implication of Drugs
Nursing Implication of Drugs Nursing Implication of Drugs
Nursing Implication of Drugs
 
Oral hypoglycemic agents
Oral hypoglycemic agentsOral hypoglycemic agents
Oral hypoglycemic agents
 
Type 2 diabetes
Type 2 diabetesType 2 diabetes
Type 2 diabetes
 
Management type 2 dm
Management type 2 dmManagement type 2 dm
Management type 2 dm
 
Treatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna SaqlainTreatment of type ii diabetes by Husna Saqlain
Treatment of type ii diabetes by Husna Saqlain
 
alpha glucosidase inhibitor
alpha glucosidase inhibitoralpha glucosidase inhibitor
alpha glucosidase inhibitor
 
alphaglucosidase inhibitors
alphaglucosidase inhibitorsalphaglucosidase inhibitors
alphaglucosidase inhibitors
 
Recent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes MellitusRecent advances in the management of Diabetes Mellitus
Recent advances in the management of Diabetes Mellitus
 

Plus de raj kumar

The umbilical cord
The umbilical cordThe umbilical cord
The umbilical cordraj kumar
 
The placenta
The placentaThe placenta
The placentaraj kumar
 
The foetal membranes
The foetal membranesThe foetal membranes
The foetal membranesraj kumar
 
Physiology of reproduction
Physiology of reproductionPhysiology of reproduction
Physiology of reproductionraj kumar
 
Minor complaints during pregnancy
Minor complaints during pregnancyMinor complaints during pregnancy
Minor complaints during pregnancyraj kumar
 
Diagnosis of pregnancy
Diagnosis of pregnancyDiagnosis of pregnancy
Diagnosis of pregnancyraj kumar
 
Antenatal care
Antenatal careAntenatal care
Antenatal careraj kumar
 
Postpartum mood disorders
Postpartum mood disordersPostpartum mood disorders
Postpartum mood disordersraj kumar
 
Normal and abnormal puerperium
Normal and abnormal puerperiumNormal and abnormal puerperium
Normal and abnormal puerperiumraj kumar
 
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)Vacuum extraction (ventouse)
Vacuum extraction (ventouse)raj kumar
 
Symphysiotomy
SymphysiotomySymphysiotomy
Symphysiotomyraj kumar
 
Forceps delivery
Forceps deliveryForceps delivery
Forceps deliveryraj kumar
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean sectionraj kumar
 
Normal labour
Normal labourNormal labour
Normal labourraj kumar
 
Anatomy of the foetal skull
Anatomy of the foetal skullAnatomy of the foetal skull
Anatomy of the foetal skullraj kumar
 
Anatomy of the female pelvis
Anatomy of the female pelvisAnatomy of the female pelvis
Anatomy of the female pelvisraj kumar
 
Active management of normal labour
Active management of normal labourActive management of normal labour
Active management of normal labourraj kumar
 
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyThyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyraj kumar
 

Plus de raj kumar (20)

The umbilical cord
The umbilical cordThe umbilical cord
The umbilical cord
 
The placenta
The placentaThe placenta
The placenta
 
The foetal membranes
The foetal membranesThe foetal membranes
The foetal membranes
 
Physiology of reproduction
Physiology of reproductionPhysiology of reproduction
Physiology of reproduction
 
Minor complaints during pregnancy
Minor complaints during pregnancyMinor complaints during pregnancy
Minor complaints during pregnancy
 
Diagnosis of pregnancy
Diagnosis of pregnancyDiagnosis of pregnancy
Diagnosis of pregnancy
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
Postpartum mood disorders
Postpartum mood disordersPostpartum mood disorders
Postpartum mood disorders
 
Normal and abnormal puerperium
Normal and abnormal puerperiumNormal and abnormal puerperium
Normal and abnormal puerperium
 
Version
VersionVersion
Version
 
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)Vacuum extraction (ventouse)
Vacuum extraction (ventouse)
 
Symphysiotomy
SymphysiotomySymphysiotomy
Symphysiotomy
 
Forceps delivery
Forceps deliveryForceps delivery
Forceps delivery
 
Episiotomy
EpisiotomyEpisiotomy
Episiotomy
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean section
 
Normal labour
Normal labourNormal labour
Normal labour
 
Anatomy of the foetal skull
Anatomy of the foetal skullAnatomy of the foetal skull
Anatomy of the foetal skull
 
Anatomy of the female pelvis
Anatomy of the female pelvisAnatomy of the female pelvis
Anatomy of the female pelvis
 
Active management of normal labour
Active management of normal labourActive management of normal labour
Active management of normal labour
 
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyThyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancy
 

Drug therapy in diabetes

  • 1. Drug therapy in Diabetes www.freelivedoctor.com
  • 2. Diagnosis of Diabetes www.freelivedoctor.com Fasting Random OGTT(2h) Normal <6 <7.8 Impair 6.1 – 7 7.8- 11.1 Diabetes >7 >11.1 + symptoms >11.1
  • 3.
  • 4.
  • 5.
  • 6. Types of Insulin www.freelivedoctor.com Insulin Lispro Aspart Neutral/ regular Isophane ultratard Glargine Onset 10-20′ 30′ 1h 4h 2-4h Peak 1h 1-3h 4-6h 6-18h peak less Duration 3-5h 4-8h 8-14h 24h 20-24h
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. Example injections Intermediate/long acting bedtime bedtime injections Biphasic insulin Biphasic insulin www.freelivedoctor.com Short acting Short acting Short acting breakfast lunch dinner breakfast lunch dinner
  • 12.
  • 13.
  • 14. Oral Medications to Treat Type 2 Diabetes www.freelivedoctor.com
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. Efficacy of Monotherapy with Oral Diabetes Agents DeFronzo Annals of Internal Medicine 1999;131:281-303 Nathan N Engl J Med 2002; 347:1342-1349 www.freelivedoctor.com
  • 22. Treatment of Type 2 Diabetes Diagnosis www.freelivedoctor.com Therapeutic Lifestyle Change Combination Therapy - Oral Drug with Insulin Combination Therapy - Oral Drugs Only Monotherapy
  • 23.
  • 24. Combination Therapy for Type 2 Diabetes Biguanides Sulfonylureas www.freelivedoctor.com Insulin Alpha-glucosidase Inhibitors Meglitinide Thiazolidinediones
  • 25.
  • 26.

Notes de l'éditeur

  1. There are five major classes of oral diabetes medications: thiazolidinediones, biguanides, sulfonylureas, meglitinides, and alpha-glucosidase inhibitors. These five classes of medication operate in essentially three different ways. Thiazolidinediones and biguanides decrease glucose production in the liver and increase insulin sensitivity in peripheral body tissues. Sulfonylureas and meglitinides stimulate the pancreatic beta cells to make more insulin. Finally, alpha-glucosidase inhibitors slow the absorption of starches in the gut, reducing the amount of glucose that enters the bloodstream.
  2. Thiazolidinediones (TZDs) enhance insulin sensitivity in muscle and adipose tissue by binding to cell receptors, which leads to an increase in glucose transporter expression. TZDs encourage beta cells to respond more efficiently by lowering the amount of glucose and free fatty acids in the bloodstream, both of which are known to be detrimental to insulin secretion. Finally, these drugs reduce glucose production in the liver. Clinical trials indicate that pioglitazone and rosiglitazone are slightly more effective at reducing A1C (1.5-1.6% reduction) than troglitazone (1.1% reduction). Some of the beneficial side effects of thiazolidinediones include an increase in HDL cholesterol and reduction of triglyceride concentrations. This class of drugs has also been shown to lower blood pressure and decrease vascular inflammation in vitro. There are clinical studies underway to further examine the cardiovascular benefit to TZDs. Some adverse effects of TZDs include weight gain, a potential increase in LDL cholesterol levels, and a possible increase in alanine aminotransferase levels (ALT). Because of the risk of weight gain, edema, and increased LDL cholesterol, thiazolidinediones are contraindicated in patients with advanced forms of congestive heart failure. Due to reported cases of liver failure and liver toxicity caused by the increase in ALT levels, TZDs are contraindicated in patients with abnormal liver function. TZDs are the most expensive of the oral antidiabetic agents.
  3. The mechanism of action of metformin is not entirely understood, but it&apos;s predominant effect is to suppress hepatic glucose production and to enhance insulin sensitivity in peripheral tissues (primarily muscle). It is unclear if insulin sensitivity occurs by metformin binding to cell receptors,which leads to an increase in glucose transporter expression, or whether insulin sensitivity is simply a secondary effect of the suppressed glucose production. Metformin&apos;s ability to lower A1C and decrease fasting plasma glucose is similar to that of sulfonylurea drugs. However, the UKPDS showed that those who received metformin had less hypoglycemia and weight gain than those who received sulfonylureas. Metformin must be avoided in patients with renal impairments, as those patients are at higher risk of experiencing lactic acidosis. However, metformin is an effective monotherapy and may be an ideal drug for overweight patients since it does not cause weight gain and has been seen to cause modest amounts of weight loss when first administered. Diarrhea and abdominal discomfort can be alleviated by changes in diet and slow increases in metformin dosage.
  4. Sulfonylureas (SUs) increase insulin secretion by binding to receptors on the surface of pancreatic beta cells, triggering a series of reactions which leads to insulin secretion. Because SUs cause circulating insulin levels to increase, there is a risk of hypoglycemia. There is also some concern that increased insulin levels are associated with cardiovascular disease, however the UKPDS did not show a relationship between increased mortality and SU administration. Finally, there is concern that SUs will exhaust beta cell function by increasing insulin secretion. However, the decline in beta cell function is more likely caused by the disease itself, and not the use of SUs. First generation sulfonylureas are just as efficacious as the second generation drugs, however the second generation may be more potent and safer than first. When diet and exercise fail, SUs are an effective monotherapy.
  5. The mechanism of action of repaglinide is similar to that of the sulfonylurea drugs: binding to beta cell receptors to stimulate insulin secretion. The major difference between the two drug classes is that meglitinides are shorter-acting, and are most effective when taken after meals in the presence of glucose. Adverse effects include weight gain and hypoglycemia. An additional drawback to this drug is the dosing schedule since it must be taken with meals.
  6. Alpha-glucosidase inhibitors (AGIs) work by blocking the enzyme in the small intestine that breaks down complex carbohydrates, alpha-glucosidase. By blocking this enzyme these drugs prevent starches from being absorbed into the bloodstream and in doing so lower blood glucose levels. AGIs are the only drug class used to treat type 2 diabetes that does not specifically target the pathology of the disease. Because AGIs work in the digestive tract, they are more effective at lowering postprandial glucose levels than fasting plasma glucose levels. On average, AGIs are less effective at lowering A1c levels than biguanides or sulfonylureas. What makes this class of drug attractive to patients and physicians is it&apos;s disassociation with weight gain and hypoglycemia. However, it is known to cause abdominal discomfort and diarrhea. AGIs are also rarely used as monotherapy because of their low efficacy.
  7. There are a number of antihyperglycemic agents available for patients with type 2 diabetes. With the exception of the alpha-glucosidase inhibitors, most of the drug classes share a similar level of efficacy. Drug therapy decisions must take into consideration patient conditions which may contraindicate the use of the drug, any adverse effects as well as any beneficial effects such as weight loss, and patient and physician preferences. In addition to taking antihyperglycemic agents, all patients with type 2 diabetes should be encouraged to maintain a healthy lifestyle by exercising and following an appropriate diet. Additional medications may also be required to treat conditions such as hypertension or dyslipidemia.
  8. This algorithm represents the logical progression of treatment for a patient diagnosed with type 2 diabetes. However, there are some exceptions. For example, there are some instances in which a patient presents with acute hyperglycemia that must be temporarily controlled with insulin. In addition, women with gestational diabetes must utilize diet or insulin therapy to control the disease, since all oral diabetes medications are contraindicated during pregnancy. Finally, it is important for the physician and patient to agree on a therapy based on the needs of the patient and the patient&apos;s comfort level with available treatment options.
  9. This slide illustrates the fixed combination pills available.
  10. As type 2 diabetes progresses it becomes more difficult to control with a single drug. When monotherapy fails to manage blood glucose levels, the logical next step is combination therapy. The goal of combination therapy is to combine the effects of two or more drugs to reach the desired A1C level. Ideally, one would combine two drugs with two different mechanisms of action, such as a drug that stimulates insulin secretion and a drug that improves insulin sensitivity. This slide illustrates approved combination therapies. Some of the most popular combinations are: 1. sulfonylurea with biguanide (metformin) 2. metformin and thiazolidinedione 3. sulfonylurea and thiazolidinedione If glycemic control is not accomplished with oral medications alone, adding insulin to the drug regimen or using insulin alone can be an effective next step.